Cite
HARVARD Citation
Jurgensen‐Rauch, A. et al. (2021). Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience. British journal of haematology. pp. 420-423. [Online].